NanoViricides has received results of detailed lab analysis studies from the initial non-GLP toxicology studies of intravenously administered FluCide. No overt adverse safety and toxicology effects were observed in this study of the ...
Software and scientific consulting services provider Certara has signed a research agreement with The Hamner Institutes for Health Sciences, to explore the scientific benefits of using its Simcyp Simulator to drive hepatic drug exposure ...
Laboratory Corporation of America (LabCorp) has launched an expanded testing menu to help clinicians diagnose, treat and monitor the course of inflammatory bowel disease (IBD). The menu comprises IBD Expanded Profile that includes ...
Tags: Labcorp, Expanded Testing Profile, Inflammatory Bowel Disease
Biognosys has developed a new MRM assay panel for the early prediction of drug toxicity in pre-clinical research studies. The LiverDig 100 assay panel, which is based on the MRM technology, is suitable for use in various pre-clinical ...
Tags: Biognosys, MRM assay panel, drug toxicity
Rainbow BioSciences' biotech division Rainbow Coral (RBCC) has revealed that it is currently working on a potential joint venture agreement with a privately held drug delivery company to develop and market a sustained-release drug delivery ...
Tags: RBCC, Sustained-Release Drug, Medicine
Merck Serono, a division of Merck, Darmstadt, Germany, and Compugen have announced the establishment of a new biomarker company, Neviah Genomics. Neviah Genomics, which is the first company to be funded within the framework of Merck ...
Tags: Compugen, Merck Serono, genomics